NCT06842199: Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis |
|
|
| Not yet recruiting | 3 | 360 | RoW | ICP-488 Tablets, ICP-488 Placebo | Beijing InnoCare Pharma Tech Co., Ltd. | Plaque Psoriasis Patients | 05/26 | 02/27 | | |
NCT05593575: Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease |
|
|
| Completed | 2 | 305 | RoW | SPH3127+SPH3127matching placebo+valsartan matching placebo, SPH3127+valsartan matching placebo, SPH3127 matching placebo+valsartan | Shanghai Pharmaceuticals Holding Co., Ltd | Diabetic Kidney Disease | 12/24 | 12/24 | | |